Jay Bradner, president of the Novartis Institutes for Biomedical Research (NIBR), is retiring from the position after seven years in the role, and will be replaced by Merck & Co R&D executive Fiona ...
Transit officials are spending billions of dollars to upgrade New York City’s aging electrical substations, the mostly ...